Nichi-Iko Pharmaceutical Co., Ltd. announced a private placement of 6,22,000 common shares at the price of ¥841 per share for gross proceeds of ¥5,231,020,000 on August 17, 2021. The transaction will include participation from MediPal Holdings Corporation. The company will issue shares through third party allocation method. The company will incur ¥40,000,000 as issuance expenses with respect to the transaction including attorney's fees and other administrative costs (securities registration statement preparation costs, payment handling bank fees, change registration costs, etc.). The transaction has been approved by board of directors of the company. The payment date for the transaction is September 2, 2021. Post the closing, MediPal Holdings Corporation will own 9.90% stake of the company.